ICAP

CoVPN 3002: The AstraZeneca Study

This randomized, double-blind, placebo-controlled multicenter study investigated the AstraZeneca (AZD1222) vaccine to prevent COVID-19

Closed to enrollment, follow up ongoing


Web Links:

https://clinicaltrials.gov/ct2/show/NCT04516746

Status

Past

Locations

Our Approach

Research

Health Challenges

COVID-19